SEARL Clarifies Reports of Acquiring Majority Stake in Abbott Laboratories

The Searle Company Limited (PSX: SEARL) has denied showing any interest in acquiring a 51 percent stake in Abbott Laboratories, the company informed the main bourse on Thursday.

“We categorically deny this claim and wish to clarify that no such discussions, negotiations, or interest have been intimated by the Company in relation to Abbot Laboratories or any acquisition of its stake,” the stock filing stated.

It said, “We advise the public and all our valued stakeholders to rely only on official announcements made by the Company through the Pakistan Stock Exchange or other approved communication channels”.

Should there be any material information requiring disclosure, the Company will duly inform the Pakistan Stock Exchange and other relevant authorities in accordance with the applicable laws and regulations, the filing added.

The Company is principally engaged in the manufacture of pharmaceuticals and other consumer products. International Brands (Private) Limited is the Parent Company, which holds 56.32 percent shareholding in the Company.

Follow ProPakistani on Google News & scroll through your favourite content faster!

Support independent journalism

If you want to join us in our mission to share independent, global journalism to the world, we’d love to have you on our side. If you can, please support us on a monthly basis. It takes less than a minute to set up, and you can rest assured that you’re making a big impact every single month in support of open, independent journalism. Thank you.



Get Alerts

Follow ProPakistani to get latest news and updates.


ProPakistani Community

Join the groups below to get latest news and updates.



>